6 December

EMA’s Brave Approach Governing AI in Medicines Regulation

22 November

Licensing of health technologies: New Report

10 February

Access to Medicines in Europe

24 April

TRIPS-flexibilities in Health Crises and Beyond

31 October

Staff Spotlight: Jaume Vidal

2 October

Medicijnen: de link met de maatschappij

7 February

Open Science for Health: Shaping the New Framework Programme

6 December

Facing a Global Threat – Roadmap to Combat Antimicrobial Resistance and the Bumps Along the Way

16 October

Staff Spotlight: Tim Reed

16 May

Staff Spotlight: Mieke Bakx

23 May

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69

28 May

Successful week of advocacy for HAI delegation at 68th World Health Assembly

4 February

The EU-US Trade Deal Could Leave Europeans Sick

28 May

Week in review: Outcomes from WHA67

26 May

World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance

26 May

World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development

5 May

Action on antimicrobial resistance: It’s about time (and we’re running out)

10 April

Tamiflu review shows desperate need for full clinical trials data transparency

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

30 January

Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed